Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Kaye

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nature Reviews. Microbiology|July 13, 2011
Leishmaniasis: complexity at the host-pathogen interfacePaul Kaye, Phillip Scott
Current Opinion in Immunology|August 6, 2003
Shaping the immune response to parasites: role of dendritic cellsAlan Sher, Edward Pearce, Paul Kaye
Plos Neglected Tropical Diseases|January 5, 2012
Single dose novel Salmonella vaccine enhances resistance against visceralizing L. major and L. donovani infection in susceptible BALB/c miceJuliane Schroeder, Najmeeyah Brown, Paul Kaye, et al.
BMJ (Clinical Research Ed.)|February 15, 2003
Leishmaniasis: new approaches to disease controlClive R Davies, Paul Kaye, Simon L Croft, et al.
Vaccine|April 20, 2013
Case study for a vaccine against leishmaniasisJorge Alvar, Simon L Croft, Paul Kaye, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|November 11, 2006
Improving computational predictions of cis-regulatory binding sitesMark Robinson, Yi Sun, Rene Te Boekhorst, et al.
Wellcome Open Research|May 30, 2023
LEISH2b - A phase 2b study to assess the safety, efficacy, and immunogenicity of the Leishmania vaccine ChAd63-KH in post-kala azar dermal leishmaniasisCharles Lacey, Ahmed Musa, El Tahir Khalil, et al.
Research Involvement and Engagement|May 31, 2021
Assessing public perception of a sand fly biting study on the pathway to a controlled human infection model for cutaneous leishmaniasisVivak Parkash, Georgina Jones, Nina Martin, et al.
Vaccine|May 11, 2005
Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantumSima Rafati, Alireza Nakhaee, Tahere Taheri, et al.
Plos Pathogens|May 16, 2007
Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infectionMagdalena Radwanska, Antony J Cutler, J Claire Hoving, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature Reviews. Microbiology|July 13, 2011
Leishmaniasis: complexity at the host-pathogen interfacePaul Kaye, Phillip Scott
Current Opinion in Immunology|August 6, 2003
Shaping the immune response to parasites: role of dendritic cellsAlan Sher, Edward Pearce, Paul Kaye
Plos Neglected Tropical Diseases|January 5, 2012
Single dose novel Salmonella vaccine enhances resistance against visceralizing L. major and L. donovani infection in susceptible BALB/c miceJuliane Schroeder, Najmeeyah Brown, Paul Kaye, et al.
BMJ (Clinical Research Ed.)|February 15, 2003
Leishmaniasis: new approaches to disease controlClive R Davies, Paul Kaye, Simon L Croft, et al.
Vaccine|April 20, 2013
Case study for a vaccine against leishmaniasisJorge Alvar, Simon L Croft, Paul Kaye, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|November 11, 2006
Improving computational predictions of cis-regulatory binding sitesMark Robinson, Yi Sun, Rene Te Boekhorst, et al.
Wellcome Open Research|May 30, 2023
LEISH2b - A phase 2b study to assess the safety, efficacy, and immunogenicity of the Leishmania vaccine ChAd63-KH in post-kala azar dermal leishmaniasisCharles Lacey, Ahmed Musa, El Tahir Khalil, et al.
Research Involvement and Engagement|May 31, 2021
Assessing public perception of a sand fly biting study on the pathway to a controlled human infection model for cutaneous leishmaniasisVivak Parkash, Georgina Jones, Nina Martin, et al.
Vaccine|May 11, 2005
Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantumSima Rafati, Alireza Nakhaee, Tahere Taheri, et al.
Plos Pathogens|May 16, 2007
Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infectionMagdalena Radwanska, Antony J Cutler, J Claire Hoving, et al.
Pageof 2